Advertisement
Screener

Starling Oncology, Inc. (STLN) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Starling Oncology, Inc. Capital Expenditures

Starling Oncology, Inc. (STLN) reported Capital Expenditures of $1.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06

  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $908.00K, a 24.83% decline year-over-year.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.04M, a 217.68% increase year-over-year.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.06M, a 39.60% decline year-over-year.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $604.00K.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $3.20M, a 15.54% decline from fiscal 2024.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $3.79M, a 17.04% decline from fiscal 2023.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $4.57M, a 17.40% decline from fiscal 2022.
  • Starling Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $5.53M, a 94.20% increase from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$908.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.95M
10-Q · filed 2026-08-06
$3.01M
derived: sum of 3 quarters · filed 2026-08-06
$3.61M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.04M
10-Q · filed 2026-05-07
$2.10M
derived: sum of 2 quarters · filed 2026-05-07
$2.71M
derived: sum of 3 quarters · filed 2026-05-07
$3.91M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$1.66M
derived: sum of 2 quarters · filed 2026-03-12
$2.87M
derived: sum of 3 quarters · filed 2026-08-06
$3.20M
10-K · filed 2026-03-12
2025-09-30$604.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.81M
derived: sum of 2 quarters · filed 2026-08-06
$2.14M
10-Q · filed 2025-11-13
$3.90M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$1.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.54M
10-Q · filed 2026-08-06
$3.29M
derived: sum of 3 quarters · filed 2026-08-06
$2.89M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$328.00K
10-Q · filed 2026-05-07
$2.08M
derived: sum of 2 quarters · filed 2026-05-07
$1.68M
derived: sum of 3 quarters · filed 2026-05-07
$3.51M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$1.35M
derived: sum of 2 quarters · filed 2026-03-12
$3.18M
derived: sum of 3 quarters · filed 2026-03-12
$3.79M
10-K · filed 2026-03-12
2024-09-30-$402.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.42M
derived: sum of 2 quarters · filed 2025-11-13
$2.03M
10-Q · filed 2025-11-13
$2.90M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$2.44M
10-Q · filed 2025-08-13
$3.30M
derived: sum of 3 quarters · filed 2025-08-13
$4.23M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$610.00K
10-Q · filed 2025-05-14
$1.47M
derived: sum of 2 quarters · filed 2025-05-14
$2.40M
derived: sum of 3 quarters · filed 2025-05-14
$3.34M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$861.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$1.79M
derived: sum of 2 quarters · filed 2025-03-26
$2.73M
derived: sum of 3 quarters · filed 2025-03-26
$4.57M
10-K · filed 2025-03-26
2023-09-30$930.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$1.87M
derived: sum of 2 quarters · filed 2024-11-13
$3.71M
10-Q · filed 2024-11-13
$5.70M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$937.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$2.78M
10-Q · filed 2024-08-13
$4.77M
derived: sum of 3 quarters · filed 2024-08-13
$5.96M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$1.84M
10-Q · filed 2024-05-14
$3.83M
derived: sum of 2 quarters · filed 2024-05-14
$5.02M
derived: sum of 3 quarters · filed 2024-05-14
$6.37M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$3.19M
derived: sum of 2 quarters · filed 2024-03-28
$4.53M
derived: sum of 3 quarters · filed 2024-03-28
$5.53M
10-K · filed 2024-03-28
2022-09-30$1.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$2.53M
derived: sum of 2 quarters · filed 2023-11-08
$3.53M
10-Q · filed 2023-11-08
$4.41M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$1.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$2.34M
10-Q · filed 2023-08-09
$3.21M
derived: sum of 3 quarters · filed 2023-08-09
$4.17M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$1.00M
10-Q · filed 2023-05-10
$1.87M
derived: sum of 2 quarters · filed 2023-05-10
$2.82M
derived: sum of 3 quarters · filed 2023-05-10
$3.23M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$871.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$1.82M
derived: sum of 2 quarters · filed 2023-03-16
$2.23M
derived: sum of 3 quarters · filed 2023-03-16
$2.85M
10-K · filed 2023-03-16
2021-09-30$950.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.36M
derived: sum of 2 quarters · filed 2022-11-09
$1.98M
10-Q · filed 2022-11-09
2021-06-30$407.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.03M
10-Q · filed 2022-08-09
2021-03-31$619.00K
10-Q · filed 2022-05-10
2020-12-31$1.19M
10-K · filed 2022-03-11